A Feasibility Study of Octreotide Infusion During Liver Transplant.
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether an octreotide infusion during liver
transplantation improves renal outcomes, intraoperative blood pressure and reduces
haemorrhage and transfusion requirement.
Phase:
Phase 2
Details
Lead Sponsor:
University College, London
Collaborator:
National Institute for Health Research, United Kingdom